
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79450 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Clomipramine Related Compound C (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormula:C19H21ClN2·HClColor and Shape:Yellow PowderMolecular weight:312.13933Gatifloxacin Related Compound D (1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Products described in u.s. note 3 to section 6 containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C18H20FN3O4Color and Shape:SolidMolecular weight:361.14378Norfloxacin Related Compound E (7-Chloro-1-ethyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C16H18ClN3O3Color and Shape:Off-White SolidMolecular weight:335.79Anagrelide Related Compound C (Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate)
CAS:Drugs containing a pyrimidine ring (whether or not hydrFormula:C12H13Cl2N3O2·HBrColor and Shape:Light Yellow PowderMolecular weight:301.03848Triacetin
CAS:Esters of acetic acid not elsewhere specified or includedFormula:C9H14O6Color and Shape:Colorless Oily LiquidMolecular weight:218.21Famciclovir Related Compound E (2-aminopurine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C5H5N5Color and Shape:PowderMolecular weight:135.0545Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C36H36N6O10Color and Shape:Off-White SolidMolecular weight:712.24929Citalopram Related Compound A (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide)
CAS:Aromatic pesticides with oxygen hetero-atom(s) only neFormula:C20H23FN2O2Color and Shape:Cream PowderMolecular weight:342.41Metomidate Hydrochloride (Methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate hydrochloride)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C13H14N2O2·HClColor and Shape:White PowderMolecular weight:266.72Imiquimod Related Compound B (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C14H15N3OColor and Shape:Yellow PowderMolecular weight:241.12151Zolmitriptan Related Compound F (2,2'-[4-(Dimethylamino)butane-1,1-diyl]bis{5-[(S)-(2-oxooxazolidin-4-yl)methyl]-3-(2-dimethylaminoethyl)indole})
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C38H53N7O4Color and Shape:Orange PowderMolecular weight:671.87Phenobarbital Related Compound B (5-Ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C12H13N3O2Color and Shape:Off-White SolidMolecular weight:231.100785-Phenylhydantoin
CAS:Hydantoin and its derivativesFormula:C9H8N2O2Color and Shape:PowderMolecular weight:176.05858Piroxicam Related Compound J (Methyl 4-hydroxy-2-methyl-2H-benzothiazine-3-carboxylate 1,1-dioxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C11H11NO5SColor and Shape:White Off-White Fine PowderMolecular weight:269.03579Testosterone Cypionate Related Compound A (Androst-4-en-3,6-dione-17β-yl 3-cyclopentylpropanoate)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormula:C27H38O4Color and Shape:Off-White SolidMolecular weight:426.59Acyclovir Related Compound F (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C10H13N5O4Color and Shape:White Yellow Crystalline PowderMolecular weight:267.24Argatroban
CAS:Sulfonamides used as drugsFormula:C23H36N6O5S·H2OColor and Shape:White Off-White PowderMolecular weight:526.25735Formyl Penicillamine (2-Formamido-3-mercapto-3-methylbutanoic acid)
CAS:Organo-sulfur compounds, nesoiFormula:C6H11NO3SColor and Shape:White PowderMolecular weight:177.04596Rivaroxaban Amine ((S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H17N3O4·HClColor and Shape:Off-White SolidMolecular weight:327.77Pyrazinamide Related Compound A (Pyrazinecarboxylic acid)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C5H4N2O2Color and Shape:White Off-White Crystalline PowderMolecular weight:124.1 g/mol

